Be in the know. 20 key reads for Thursday…

  1. Coty Is One of 2020’s Worst-Performing Stocks. Why an Analyst Says Its Time to Buy. (Barron’s)
  2. Chevron Is Now the Biggest U.S. Oil Stock. (Barron’s)
  3. Emerging Markets Are Looking Attractive. Strategists Are Still Wary. (Barron’s)
  4. Cruise Stocks Are Climbing After a J.P. Morgan Analyst Boosts Price Targets (Barron’s)
  5. Wynn Resorts Stock Can Double: Fund Manager (Barron’s)
  6. Regeneron seeks emergency approval for COVID-19 drug that Trump took (New York Post)
  7. Eli Lilly seeks emergency use of its antibody drug for COVID-19 (New York Post)
  8. Fleetwood Mac’s ‘Dreams’: Mick Fleetwood recreates viral, cranberry juice-swigging TikTok video (USA Today)
  9. Westchester Home Prices Pushed to Record High By Bidding Wars (Bloomberg)
  10. Trump Says Eli Lilly Drug to Be Approved And He’s Not Contagious (Bloomberg)
  11. Hydrogen’s Dirty Little Secret (Wall Street Journal)
  12. Exxon Could Get a Chemical Turbo Boost if Oil Rebounds (Wall Street Journal)
  13. Lyft Orders Up a Side Dish (Wall Street Journal)
  14. Molson Coors (TAP) PT Raised to $62 at Guggenheim, Named ‘Best Idea’ (Street Insider)
  15. Wells Fargo cuts more jobs as part of earlier cost-cutting drive (Street Insider)
  16. Trump calls contracting coronavirus ‘blessing from God’ as Regeneron files for FDA approval (MarketWatch)
  17. Can Airport Covid Testing Get People Flying Again? (Wall Street Journal)
  18. Onto a new cloud — IBM to spin off managed infrastructure services unit (MarketWatch)
  19. Bausch Health shares jump 6% premarket after company offers upbeat revenue guidance (MarketWatch)
  20. AMC Entertainment expects 520 of its 600 U.S. theaters to be open by mid-October (MarketWatch)